COVID-19 information for researchers and sponsors
Southampton is part of the national effort to prevent, diagnose and treat COVID-19.
For the foreseeable future we will concentrate on maintaining research studies:
- a) that relate directly to COVID-19, or
- b) where patient safety may be compromised if they were to be suspended
This is in line with National Institute of Health Research (NIHR) guidance, and we have worked with each principal investigator to assess their studies and reach a decision.
Non priority research studies
In order to deliver national priority COVID-19 studies and trials where interruption may compromise the safety or health of vulnerable patients, the R&D department has suspended a large number of other studies.
This is temporary and studies will be resumed when it is safe and appropriate to do so.
No new studies will be set up until further notice, and recruitment to open studies will cease, unless it is in patients’ best interests.
Contact point for investigators and research teams
Please contact email@example.com with any concerns or queries about individual studies or general R&D policy.
We will maintain a core team to answer emails and telephone calls but ask for your patience if your question is not answered immediately. The R&D department is operating with a reduced staff due to sickness, self-isolation and redeployment to other key areas of the hospital.
Specific information about expressions of interest, monitor visits and sponsor amendments can be downloaded here